Terms and conditions of Use

NovoCare® Pharmacy (CoAssist Pharmacy d/b/a NovoCare® Pharmacy)

Covered products

Wegovy® (semaglutide) injection 2.4mg

Total strength per total volume

NDC


0.25 mg/0.5 mL

0169-4525-14


0.5 mg/0.5 mL

0169-4505-14


1 mg/0.5 mL

0169-4501-14


1.7 mg/0.75 mL

0169-4517-14


2.4 mg/0.75 mL

0169-4524-14

Eligibility and Restrictions

In order to participate in this program, patient must have a valid prescription for the brand being filled. A valid Prescriber ID# is required on the prescription. Patient is not eligible if enrolled in any federal or state health care program with prescription drug coverage, such as Medicaid, Medicare, Medigap, VA, DOD, TRICARE, or any similar federal or state health care program (each a Government Program), or where prohibited by law.

Patients may participate in this program if they are uninsured or have commercial insurance. If the patient has commercial insurance and fulfills their prescription through this program, the transaction will process outside of any insurance. Patient payments will not count toward any deductibles and cannot be applied to a patient’s maximum out-of-pocket costs.

By using this program, patients certify that he/she meets the eligibility criteria and will comply with the terms and conditions described herein and will not seek reimbursement for any medication received through this program.

Novo Nordisk’s Eligibility and Restrictions, and Program Details, may change from time to time, and for the most recent version, please visit this webpage. Reconfirmation of patient information may be requested periodically to ensure accuracy of data and compliance with terms. Patients with questions about the program may call 1‑888‑809‑3942.

This offer is valid only in the United States and its territories, unless prohibited by law.

Program Details

NovoCare® Pharmacy is a cash-pay pharmacy and insurance is not accepted.

When a prescription is received by a licensed prescriber, NovoCare® will review and validate the prescription. NovoCare® will conduct a benefit investigation to determine the patient’s coverage status and out-of-pocket cost, where applicable. Patients with insurance coverage for Wegovy® will have the option to utilize the cash program through CoAssist Pharmacy d/b/a NovoCare® Pharmacy (“NovoCare Pharmacy”) or transfer the prescription to a retail pharmacy if they choose to apply their prescription insurance to the prescription fulfillment.

Patients enrolled in this program can pay $499 per month, equivalent to a 28-day supply or 1 box. Patients must provide payment prior to dispensation of each 1-month supply.

Assurance of Medication Supply

This program will continue to enroll patients so long as each enrolled patient can receive a consistent supply of medication. This assurance is only applicable for those patients who remain enrolled and adherent to the treatment. Novo Nordisk reserves the right to pause or terminate enrollment to prioritize supply for those qualified.

Disclosure of Third-Party Partnerships

AssistRx: A patient solutions provider responsible for NovoCare®’s access and reimbursement live support program. They manage patient intake, outreach, and verification of insurance coverage.

CoAssist: A licensed pharmacy in all 50 US States and territories that for purposes of this program is CoAssist Pharmacy d/b/a NovoCare Pharmacy. CoAssist takes in the prescription after the NovoCare®’s access and reimbursement live support program reviews patient’s insurance type and benefits investigation to determine eligibility for program. Eligible patients then have their HCP’s prescription transferred from CoAssist to CenterWell Pharmacy, where CenterWell further validates the prescription, and processes it for shipment to patient’s home.

CenterWell: NovoCare®’s dispensing pharmacy responsible for patient accounts, payment collection, medication fulfillment, tracking, and shipping.